163 related articles for article (PubMed ID: 38446235)
21. Care and treatment of peristomal gangrenous pyoderma. A study of three cases.
Julve-Herraiz L; Villalba-Ferrer F; García-Coret MJ; García-Costa B
Enferm Clin (Engl Ed); 2021; 31(2):120-125. PubMed ID: 33541774
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics of peristomal pyoderma gangrenosum: A Single Center Retrospective Observational Study.
Honma M; Sugawara M; Ueno N; Honma M; Hinooka R; Tani C
J Dermatol; 2022 Nov; 49(11):1178-1182. PubMed ID: 35789032
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
Argüelles-Arias F; Castro-Laria L; Lobatón T; Aguas-Peris M; Rojas-Feria M; Barreiro-de Acosta M; Soto-Escribano P; Calvo-Moya M; Ginard-Vicens D; Chaparro-Sánchez M; Hernández-Durán M; Castro-Senosiain B; Fernández-Villaverde A; García-Sánchez V; Domínguez-Muñoz E; Caunedo-Álvarez A; Herrerías-Gutiérrez JM
Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140
[TBL] [Abstract][Full Text] [Related]
24. Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
Wang J; Prenner J; Wang W; Sakuraba A; Hyman N; Dalal S; Hurst R; Cohen RD; Umanskiy K; Shogan BD; Alpert L; Rubin DT; Colwell J; Pekow J
Aliment Pharmacol Ther; 2020 Jun; 51(12):1365-1372. PubMed ID: 32383278
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.
Sawka E; Zhou A; Latour E; Friedman M; Ortega-Loayza AG
Clin Rheumatol; 2021 Oct; 40(10):3963-3969. PubMed ID: 34002351
[TBL] [Abstract][Full Text] [Related]
26. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
27. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
[TBL] [Abstract][Full Text] [Related]
28. Pyoderma gangrenosum versus chronic venous ulceration: comparison of diagnostic features.
Koo K; Brem H; Lebwohl M
J Cutan Med Surg; 2006; 10(1):26-30. PubMed ID: 17241569
[TBL] [Abstract][Full Text] [Related]
29. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
30. Peristomal pyoderma gangrenosum in a patient with inflammatory bowel disease.
Garcia Dominguez A; Saralegui Ansorena Y; Artola Etxeberria M; Enríquez-Navascués JM
Cir Esp (Engl Ed); 2021; 99(6):464. PubMed ID: 34130816
[No Abstract] [Full Text] [Related]
31. Pyoderma Gangrenosum: A Review for the Gastroenterologist.
Plumptre I; Knabel D; Tomecki K
Inflamm Bowel Dis; 2018 Nov; 24(12):2510-2517. PubMed ID: 29788368
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of post-surgical pyoderma gangrenosum: identification of risk factors and proposed management strategy.
Zuo KJ; Fung E; Tredget EE; Lin AN
J Plast Reconstr Aesthet Surg; 2015 Mar; 68(3):295-303. PubMed ID: 25589459
[TBL] [Abstract][Full Text] [Related]
33. The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.
Ashchyan HJ; Butler DC; Nelson CA; Noe MH; Tsiaras WG; Lockwood SJ; James WD; Micheletti RG; Rosenbach M; Mostaghimi A
JAMA Dermatol; 2018 Apr; 154(4):409-413. PubMed ID: 29450453
[TBL] [Abstract][Full Text] [Related]
34. Development of pyoderma gangrenosum during therapy with infliximab.
Jaimes-López N; Molina V; Arroyave JE; Vasquez LA; Ruiz AC; Castaño R; Ruiz MH
J Dermatol Case Rep; 2009 Aug; 3(2):20-3. PubMed ID: 21886723
[TBL] [Abstract][Full Text] [Related]
35. Peristomal pyoderma gangrenosum (PG): A simple hydrocolloid dressing technique to promote wound healing.
Rodenbeck DL; Kennon AW; Davis LS
J Am Acad Dermatol; 2015 Sep; 73(3):e107-8. PubMed ID: 26282808
[No Abstract] [Full Text] [Related]
36. Case to highlight a rare differential diagnosis of necrotising fasciitis in the presence of a stoma: peristomal pyoderma gangrenosum.
Chong C; Palanisamy P; Yeo ES
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33962915
[TBL] [Abstract][Full Text] [Related]
37. Peristomal Pyoderma Gangrenosum in a Rectal Cancer Patient With an Ileostomy: A Case Study.
Cerdán Santacruz C; Lancharro Bermúdez M; Caparrós Sanz MR; Cerdán Miguel J
J Wound Ostomy Continence Nurs; 2020; 47(4):403-406. PubMed ID: 33290020
[TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis.
Behm K; Larson DW; Colibaseanu D
J Surg Case Rep; 2015 Mar; 2015(3):. PubMed ID: 25802252
[TBL] [Abstract][Full Text] [Related]
39. [Pyoderma gangrenosum peristomal in ulcerative colitis; first report of a case in Mexico].
Vergara-Fernández O; Vega R; Morales-Olivera JM; Gamboa-Domínguez A; Uscanga L; Takahashi-Monrroy T
Rev Gastroenterol Mex; 2008; 73(2):89-92. PubMed ID: 19666253
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and treatment of peristomal pyoderma gangrenosum.
Hughes AP; Jackson JM; Callen JP
JAMA; 2000 Sep; 284(12):1546-8. PubMed ID: 11000649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
